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ABSTRACT
Extended-spectrum b-lactamase (ESBL) produc-
tion was demonstrated in five independent,
multidrug-resistant isolates of enteroaggregative
Escherichia coli (EAEC) from the United Arab
Emirates, representing 11.3% of the EAEC iso-
lates recovered during 1 year. All five isolates
carried the blaCTX-M-15 and the blaTEM-1 genes, the
former positioned 48 bp downstream of an ISecp1
element. In two isolates, the blaCTX-M-15 and
blaTEM-1 genes were located on a 95-kb plasmid.
This is the first detailed description and charac-
terisation of ESBL production in enteroaggrega-
tive E. coli and also the first report of CTX-M-
producing organisms encountered on the Arabian
Peninsula.
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Antibiotic resistance among diarrhoea-causing
bacterial pathogens is a major concern world-
wide, with the production of various extended
spectrum b)lactamases (ESBLs) being a rapidly
emerging problem. In particular, plasmid-encod-
ed cefotaximases (CTX-M enzymes) have shown a
remarkable ability to spread, not only among
nosocomial pathogens, but also among microor-
ganisms causing enteric infections in the commu-
nity [1].
Enteroaggregative Escherichia coli (EAEC) cau-
ses diarrhoea among travellers, but also fre-
quently infects residents of developing and
developed countries [2,3]. EAEC attach to the
intestinal mucosa and induce increased mucus
production and an inflammatory response. EAEC
represent a heterogeneous group of strains that
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are often also isolated from healthy individuals
[2–4]. Isolates resistant to a broad range of
antibiotics, including fluoroquinolones, have been
encountered increasingly [5–8]. Recently, EAEC
resistant by unknown mechanisms to ceftazidime
and ceftriaxone were isolated in India [9]. In the
present study, the incidence and the genetic
background of resistance to third-generation ce-
phalosporins were investigated in EAEC from the
United Arab Emirates (UAE).
Forty-four EAEC isolates, identified by a viru-
lence plasmid-specific PCR [10], from a set of
stool samples (116 from children aged < 4 years
with diarrhoea, 100 from adults with diarrhoea,
and 110 from adults without diarrhoea) collected
at Al Ain Hospital, UAE, were included in the
study. All isolates were recovered between
April 2003 and May 2004. Five (11.3%) of the
44 EAEC isolates (isolates 364, 540, 705, 742 and
971) exhibited resistance to at least one of the
third-generation cephalosporins (i.e., ceftazidime,
cefotaxime or ceftriaxone) when tested by disk-
diffusion. ESBL production was confirmed by
Etests (AB Biodisk, Solna, Sweden) for ceftazi-
dime or cefotaxime, with and without clavulanic
acid (data not shown).
Four of the five isolates were recovered from
children with acute, non-bloody diarrhoea, while
one isolate was from an adult with similar
symptoms. Three of the children and the adult
had not received antibiotics and had not left the
UAE within the 3 months preceding onset of the
disease. No data were available for the fourth
child. One child also excreted Shigella sonnei and
one also excreted Salmonella enterica group B
(these isolates did not produce ESBL). The isolates
were serotyped using O- and H-specific typing
sera produced in rabbits at the ‘Be´la Johan’
National Center for Epidemiology, Budapest,
Hungary. DNA sequences specific for some of
the putative virulence factors, i.e., enteroaggrega-
tive virulence plasmid (eagg), aggregative adher-
ence factors AAF I, II and III (aagA, aafA, aag3A),
enteroaggregative heat stable enterotoxin (astA),
plasmid-encoded toxin (pet), cytolethal distending
toxin (cdtB), siderophore receptor (fyuA), and the
yersiniabactin biosynthesis genes on the Yersinia
high pathogenicity island (irp2), were detected by
PCR [4,9–12]. The serotype, genotype and antibi-
otic sensitivities of the isolates (Table 1) suggested
that they were unrelated. This was further corro-
borated by their XbaI macrorestriction profiles,
obtained after pulsed-field gel electrophoresis
[13], which showed more than seven band differ-
ences [14] (data not shown).
Sequences specific to blaTEM and blaCTX-M genes,
but not to blaSHV, were detected in the DNA
extracts from the five isolates by PCR [15], and
were sequenced in both directions by fluorescent-
based direct sequencing using the ABI Prism Dye
Terminator cycle sequencing ready reaction kit
(PE Applied Biosystems, Warrington, UK) and an
ABI Prism 310 genetic analyser (PE Applied
Biosystems). The primers used for amplification
Table 1. Characteristics of ESBL-producing enteroaggregative Escherichia coli isolates and their derivatives
Isolate
(serotype)
Genotype
Antibiotic susceptibility disk-
diffusion tests MIC (mg ⁄L)
eagg aagA aafA aag3A astA pet cdtB fyuA irp2 AMP AMC ⁄CL IMI GE AK TE TMP ⁄SMX C CIP NA CAZ CTX CRO AZT FEP
742 + + – – – – – + + R R S S S R R R I R 16 128 96 16 8
(O90:HNT)
705 + + – – + – – – – R I S S S R R R R R 32 >256 >256 24 16
(O153:HNT)
364 + – – – – – – + + R I S R S S R R S R 24 >256 >256 24 16
(O25:H4)
540 + – + – – – – + + R S S S S R S R S R 8 256 64 16 8
(ONT:H21)
DH5a (p540)a – ND ND ND ND ND ND ND ND R S S S S S S S S S 8 64 64 8 3
(rough)
971 + – – – – – – + + R R S S S R R R S S 32 >256 >256 64 32
(O153:HNT)
DH5a (p971)b – ND ND ND ND ND ND ND ND R S S S S S S S S S 16 64 48 12 3
(rough)
J53S (p971)c – ND ND ND ND ND ND ND ND R R S S S S S S S R 8 64 32 12 1,5
(rough)
a,bTransformants with 95-kb plasmids from wild-type strains 540 and 971, respectively;
cTransconjugant with 95-kb plasmid from wild-type isolate 971 (this transconjugant also acquired 52-kb and 1.8-kb plasmids; see text.
ND, not done; R, resistant; I, intermediately-sensitive; S, sensitive; AMP, ampicillin; AMC ⁄CL, amoxycillin-clavulanic acid; IMI, imipenem; GE, gentamicin; AK, amikacin; TE,
tetracycline; TMP ⁄ SMX, trimethoprim-sulphamethoxasole; C, chloramphenicol; CIP, ciprofloxacin; NA, nalidixic acid; CAZ, ceftazidime; CTX, cefotaxime; CRO, ceftriaxone;
AZT, aztreonam; FEP, cefepime.
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and sequencing of blaTEM were overlapping pairs
of oligonucleotides C and D [15], and TEM1do1Fo
(ACTGCTGCCAACTTACTTCT) and TEM1do1
Re (AAACTTGGT CTGACAGTTAC), the latter
two binding at nucleotides 24440 and 24926 of the
published sequence of blaTEM [16] (GenBank
accession no. AY458016). Apart from the CTX-M
primers MA-1 and MA-2 [15], complete sequenc-
ing of the blaCTX-M gene was performed with
primers 403Fo (GTGTTGCTCTGTGGATAACT),
1040Re (ACGTTATCGCTGTACTGTAG), 1166Fo
(GCGATCCGCGTGATACCACT), and 1671Re
(CGTGGCTGCCGATGACTATG), which anneal-
ed at the indicated positions flanking the up-
stream and downstream ends of the CTX-M 15
gene (GenBank accession no. AY604722).
All five EAEC isolates carried the TEM-1 gene
[16], while the blaCTX-M sequences and the 201-bp
upstream regions showed complete identity with
the first CTX-M-15 enzyme described (GenBank
accession no. AY044436) [17]. The upstream
region contained the 3¢-end of the ISecp1 element
with the right inverted repeat (IRR), and with
tentative ) 10 and ) 35 sequences 48 bp upstream
of the start codon of the ESBL gene [17]. The
sequence of the EAEC blaCTX-M-15 has been sub-
mitted to GenBank (accession no. AY960984).
Conjugative transfer of cefotaxime resistance
was attempted by co-culturing the donors with E.
coli J53-S (met, pro, StrR) on 47-lm nitrocellulose
filters laid on Tryptic Soy Agar, followed by
selection for transconjugants on medium contain-
ing cefotaxime 5 mg ⁄L and streptomycin
200 mg ⁄L. Although different donor and recipi-
ent ratios were used, transconjugants were
obtained only with isolate 971 as the donor, with
transfer of cefotaxime resistance always accom-
panied by co-transfer of 95-kb (p971), 52-kb and
1.8-kb plasmids. DNA extracts of the transconju-
gants yielded positive signals with the blaTEM and
blaCTX-M-specific primers, and the sequence of the
blaCTX-M gene and its immediate upstream envi-
ronment was identical to that of the wild-type
isolates. Attempts were also made to transfer
blaCTX-M by electroporation into E. coli DH5a
(endA1, gyrA96) using total plasmid DNA pre-
pared with the Qiagen Plasmid Mini Kit (Qiagen,
Hilden, MD, USA). Transformants carrying
blaCTX-M and blaTEM on a single 95-kb plasmid
were obtained using extracts from isolates 540
and 971. None of the transconjugants and trans-
formants acquired resistance beyond that to
b-lactam antibiotics, and they did not carry the
EAEC virulence plasmid specific sequences
(Table 1).
Surprisingly, CTX-M-15-expressing EAEC iso-
lates had lower ceftazidime MICs (Table 1) than
those often reported for this enzyme [1]. The
Asp-240 ﬁ Gly substitution in CTX-M-15 usually
results in increased activity against ceftazidime
compared with other CTX-M enzymes [1]. How-
ever, strains producing CTX-M-15 with low activ-
ity against ceftazidime have also been
encountered in the UK [18]. As in the present
study, resistance to amoxycillin-clavulanic acid
(Table 1) has been observed previously in CTX-
M-15-producing strains from different continents,
and is related to the overproduction of chromo-
somal AmpC or another b-lactamase [16,19].
This is the first report of CTX-M-15-producing
strains from the Arabian Peninsula, and is the first
study characterising the ESBLs produced by
EAEC. Previously, only a few aggregative strains
with ESBL production had been noted in Poland,
but the type and the genetic background of the
enzymes involved were not investigated [20].
Orally administered broad-spectrum cephalospo-
rins are currently not considered to be drugs of
choice for treating EAEC infections. Nevertheless,
the presence of ESBL-encoding genes in EAEC
can have far reaching implications. Rapidly
spreading resistance factors, such as the plas-
mid-encoded blaCTX-M-15 gene associated with
ISecp1 [1,16–19], in pathogens known to colonise
healthy individuals [2–4] could transfer easily to
more invasive organisms, in which case resistance
to these drugs may seriously endanger the suc-
cess of therapy.
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ABSTRACT
Exfoliative toxin D (ETD) was identified recently
as a new exfoliative toxin serotype. Like other
exfoliative toxins, ETD induces intra-epidermal
cleavage through the granular layer of the epi-
dermis of neonatal mice. The distribution of ETD
production was investigated in Staphylococcus
aureus isolates from infected and colonised
patients in France. The etd gene was found in 55
(10.5%) of 522 isolates tested. Isolates responsible
for bullous impetigo and generalised staphylo-
coccal scalded skin syndrome did not harbour etd,
but etd was significantly more frequent in isolates
causing cutaneous abscesses and furuncles. Most
etd- and Panton–Valentine leukocidin-positive
strains belonged to the clone of community-
acquired methicillin-resistant S. aureus spreading
currently throughout France.
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